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1Cardiology patients’ medicines management networks after hospital discharge: a 
mixed methods analysis of a complex adaptive system
Abstract
Introduction
The complex healthcare system that provides patients with medicines places them at risk 
when care is transferred between healthcare organisations, for example discharge from 
hospital. Consequently, understanding and improving medicines management, particularly at 
care transfers, is a priority.
Objectives 
This study aimed to explore the medicines management system as patients experience it 
and determine differences in the patient-perceived importance of people in the system.
Methods
We used a Social Network Analysis framework, collecting ego-net data about the importance 
of people patients had contact with concerning their medicines after hospital discharge. 
Single- and multi-level logistic regression models of patients’ networks were constructed, 
and model residuals were explored at the patient level. This enabled us to identify patients’ 
ego-nets with support tie patterns different from the general patterns suggested by the model 
results. Qualitative data for those patients were then analysed to understand their differing 
experiences. 
Results
Ego-nets comprised clinical and administrative healthcare staff and friends and family 
members. Ego-nets were highly individual and the perceived importance of alters varied both 
within and between patients. Ties to spouses were significantly more likely to be rated as 
highly important and ties to community pharmacy staff (other than pharmacists) and to GP 
receptionists were less likely to be highly rated. Patients with low-value medicines 
management networks described having limited information about their medicines and a lack 
of understanding or help. Patients with high-value networks described appreciating support 
and having confidence in staff.
Conclusions
Patients experience medicines management as individual systems within which they 
interacted with healthcare staff and informal support to manage their treatment. Multilevel 
models indicated that there are unexplained variables impacting on patients’ assessments of 
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2their medicines management networks. Qualitative exploration of the model residuals can 
offer an understanding of networks that do not have the typical range of support ties.
Keywords: medication management; social network analysis; medication error; multilevel 
models; patient safety; healthcare systems.
Introduction
The healthcare system that provides patients with their medicines can also place them at 
risk, especially when their care is transferred between healthcare providers, for example, at 
hospital discharge.1 Among the risks to patient safety in the transfer of care are poor 
communication between care providers about changes to prescribed medicines during the 
hospital admission,2 3 the insufficient provision of information to patients about their 
medicines when they leave hospital,4 and deficits in the quality of medicines reconciliation.5 
Medicines management is the UK healthcare system that supports the prescribing, 
dispensing, monitoring, reviewing and use of medicines.6-8 It is a multi-professional, socio-
technical system within which patients interact with different healthcare professionals.9 
These professionals often work from different sites and settings such as hospitals, GP 
practices, specialist clinics and community pharmacies, and use different technical systems 
to support care. People in the system may operate independently yet concurrently and the 
system can be unpredictable. For example, patient responses to changes to medicines may 
not be as expected and one organisation may not respond to instructions or communications 
made by another, for example not implementing recommendations for changed medicines 
by specialists. In this way the medicines management system can be considered a complex 
adaptive system. Complex adaptive systems thinking recognises complexity, accepting that 
linear ‘cause and effect’ models of healthcare are too simple and do not take into account 
the decentralised structure of care and dispersed system controls.10 System performance or 
behaviours in complex adaptive systems are unpredictable, networks of ‘agents’ in the 
system react to the actions of others and connections between agents in the system are 
critical to success or survival.11 
Fraser and Greenhalgh (2001) described several properties of complex adaptive systems, 
which we have considered in the context of medicines management and presented in Table 
1. 
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3Table 1: Examples of the features of complex adaptive systems applied to medicines management adapted from 
Fraser and Greenhalgh 2001 12
Features of complex adaptive 
systems
Examples in medicines management
The system and its external 
environment are not constant
People – such as clinicians or spouses – in the 
system change depending on patients’ access to 
services and informal support, health condition, and 
co-morbidities. The environment in which medicines 
are taken also varies.
Individuals in the system are 
independent and creative decision 
makers
Each patient and clinician makes decisions about 
which medicines are prescribed and taken, how they 
are titrated, how they are monitored and how they are 
managed in the home.
Uncertainty and paradox are 
inherent
Patient responses to treatment vary and treatment for 
one condition may impact on another condition. 
Problems cannot always be solved 
but they can be improved
Many chronic conditions cannot be cured, only 
managed with medicines.
The inherent risks in the transfer of care can be 
reduced but not eliminated.
Effective solutions can emerge 
from minimum specification
A small improvement to document the reason why a 
medicine has changed is not difficult to achieve yet it 
can substantially improve safety.
Small changes can have big effects Changes made to treat one health condition may 
have adverse impacts on patients’ co-morbidities. 
Actions taken or not taken by one person in the 
system can cause a safety incident which can 
manifest in a different part of the system.
Behaviour exhibits patterns (can be 
termed ‘attractors’)
Patients order medicines through their GP practices 
and would normally have them dispensed in the 
same community pharmacy.
GP practices would usually have a process for 
processing discharge summaries.
Patients may have an established routine or process 
for managing their medicines.
Change is more easily adopted 
when in taps into these patterns
Co-design with exiting patients of self-management 
routines would tap into their existing management 
patterns.
In the UK, the National Health Service (NHS) aspires to healthcare that is person-centred,13 
taking into account their individual needs and preferences. Medicines management is 
characterised by a focus on personal interactions,14 and as care recipients, patients have a 
view of care interactions that may not be afforded to others in the system. However, many 
patients’ experiences of navigating this system are less than optimal: they can be confused 
by the information they have (or have not) been given about their medicines,4 15  and they 
spend time actively monitoring for errors made by healthcare professionals. 16 17 
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4Patients are usually discharged from the hospital in the UK with a supply of medicines of up 
to 4 weeks and information about the patient’s new list of medicines is sent to their primary 
care practice. Information is not routinely sent to community pharmacy unless the patient 
uses a multi-compartment compliance aid. Their next prescription will be issued by their GP 
and either sent to their community pharmacist or collected by the patient and taken to the 
community pharmacy to be dispensed. Many cardiology patients are referred by the hospital 
to cardiac rehabilitation and heart failure nursing services, which provide care for a specified 
period. Waiting times for these services are increasing nationally and the number of patients 
with co-morbidities that access them is also increasing.18 
Given the evident complexity in the medicines management system and the impact this has 
on patients, this study aimed to explore and appraise the composition of the medicines 
management system from the patient viewpoint to understand how this healthcare system 
operated after hospital discharge and the range of different healthcare professionals who 
comprise the system that patients must navigate. Viewing healthcare systems as social 
networks allows the type and value of care and support patients receive from healthcare 
professionals and patients’ own informal contacts to be considered. Consequently, a Social 
Network Analysis (SNA) framework was judged to be the most suitable methodology. 
 The overall objectives of the study were to: 
1 Describe the medicines management system from the patient perspective.
2 Understand which professional and personal ties, such as community pharmacy, 
GPs and administrative staff, perform important functions for patients.
Theoretical model
We characterised the medicines management system as a personal network (an ego-net), in 
which the patients were the ‘egos’ and the people they interacted with concerning their 
following their discharge were their network members. The ties between patients and 
network members were patient assessments of the importance of that person to them in 
managing their medicines, and these ties were the units of analysis.
Ego-net analysis of medicines management
There are few published studies using ego-net or personal network approaches to explore 
how medicines are managed. Qualitatively, Kjos et al. (2011) explored medicines information 
seeking personal networks, finding that patients sought medicines information from both 
HCPs and informal network members, such as their family and friends, some of whom had 
healthcare experience.19 A further study used an ego-net approach to explore roles in 
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5multidisciplinary care teams, describing and comparing patients’ health networks, gaining an 
understanding of their interactions, and identifying the community pharmacists’ roles within 
asthma patients’ networks.20 More recently, Cheraghi-Sohi et al. (2015) explored how 
personal network members influenced medicines-taking amongst 20 people with long-term 
conditions.17 The authors used the concept of ‘medicines work’ to explore the roles of others 
in enabling medicines taking. They found that personal network members performed tasks 
such as collecting and monitoring medicines, offering emotional support, and providing 
information to patients. 
Methods
Study setting and recruitment
We collected data about the people cardiology patients had contact with relating to their 
medicines via diaries and face-to-face semi-structured interviews during a six-week period 
following their discharge from two hospitals in the North of England. Site 1 was a 900-bed 
hospital forming part of an NHS teaching hospital foundation trust serving a population of 
approximately 0.5 million people in 100,000 households. According to Public Health 
England, over a quarter of adults in the areas were classified as obese and smoking related 
deaths were worse than the English average. Early deaths (people under 75 years of age) 
from heart disease and stroke had been consistently higher than the English average.
Site 2 was a 690-bed hospital which forms part of a NHS trust, again serving a population of 
just over 0.5 million people. It covered the populations of several different unitary authorities 
and districts, most of which are highly deprived. Indeed, in all but one area served by the 
site, life expectancy for men and women was lower than the national average and the rates 
of cardiovascular disease and obesity were higher than the national average.21 A quota 
sample of 60 patients was constructed to ensure patients with different characteristics – 
socio-economic status measured by the Index of Multiple Deprivation value of the patient’s 
postcode, gender and age – were present in the final sample. 
Eligible patients were approached on the day of discharge by one experienced healthcare 
researcher (BF) who explained the study to them, gave them the patient information leaflet, 
which they were given time to read and to discuss with friends or family if they wished to do 
so. Patients who were willing to take part completed and signed a consent form. The 
researcher explained to the patient how to keep the diary records and agreed that the patient 
would be contacted by telephone after few days to see how they were managing their diaries 
and to arrange set-up of the subsequent interview. NHS Research Ethics Committee 
approval was obtained (13/NI/0118).
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6Data collection
Data were collected between November 2013 and June 2014. During the six weeks 
following their discharge, patients were asked to keep paper diary records of the people they 
had had contact with concerning their medicines. They were asked to record each day in 
their diaries the contacts that had been made, the role of the person or relationship to them. 
There was space in the diary for the purpose and the mode (e.g. telephone) of the contact to 
be noted. We did not predefine who they should include, however patients were given 
examples of the types of contact they might record, for example GPs, nurses, pharmacists, 
friends and family. They were also given example diary records as shown in Table 2 and 
given the researcher’s contact details to use if they had queries.
Table 2: Example diary records given to patients in the study
Date People I 
contacted
People who 
contacted 
me
Role / 
relationship 
to me
Contact 
type
What happened
15/09/13 Helen Sister-in-law Telephone Told me to follow my 
discharge medicines 
instructions carefully
16/09/13 No contact No contact
17/09/13 Pharmacist 
(supermarket)
Pharmacist In person I asked for indigestion 
tablets
18/09/13 Pharmacist 
(Helen)
Pharmacist In person Reviewed my medicines 
– She said she would 
write to my GP to 
suggest some changes
Diaries were used as prompts during semi-structured interviews held approximately six 
weeks following discharge from hospital. The interview schedule was constructed so that 
contact data could be collected during interviews if patients did not wish to keep a diary or 
did not feel able to do so. The semi-structured interview schedule comprised questions, 
probes and prompts exploring patients’ experiences with their medicines since leaving the 
hospital and the contact they had had with healthcare professionals and others concerning 
their medicines. During interviews a hierarchical personal network tool was used to collect 
data about patients’ medicines networks following previously applied methods.20 22 This was 
done by showing patients a circular diagram with numbered concentric circles which was 
used to position their network members (shown in Figure 1). The circle nearest the centre 
was labelled ‘1’ and outer circles 2, 3 and 4. The interviewer explained to the patient that 
they should indicate where each of the people identified in their networks should be 
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7positioned based on how important the patient thought that person was to managing their 
medicines. A ranking of 1 was the most important and 4 the least important so the closer 
they placed them to the middle of the diagram, the more important the patient perceived that 
person to be.  Patients were asked ‘How would you rate the contacts involved in your 
medicines?’ ‘Why do these people play a bigger role than others in your medicines?’, ‘Why 
are these people not so important?’ and ‘How much do you feel each of these people listen 
to you? And understand you?’ The names and positions of patients’ medicines contacts 
formed their ego-nets for quantitative analysis. An example of the tool used is shown in 
Figure 1.
Figure 1: An example of the hierarchical network took used to capture patients' networks
Data analysis
Members of patients’ networks were categorised into ten types based on their professional 
role or their relationship with the patient. There were eight professional types and two 
personal types. Tie values (recorded as 1 = highest value; 4 = lowest value) were reversed. 
Tie values were then dichotomised: for each network member the highest value was 
recorded as ‘1’ values of ‘1-3’ were recorded as ‘0’.
Data were analysed in SPSS v.22 using descriptive statistics to explore the composition of 
patients’ networks and the importance of the types of network members. Data were then 
analysed using inferential statistics to explore the variation in importance for different 
network member types and whether network ties varied from patient to patient as well as by 
type of tie. This was also done to give insight into whether experiences of medicines 
management were different for each patient regardless of their network composition. A 
single-level logistic regression model was fitted in the statistical programme R23 linked to 
MLWIN v 2.35.24-26 The outcome variable was the dichotomised importance value. 
Explanatory variables were the site, the patient’s age, the patient’s gender, and the role or 
relationship of the network member. The reference category for patient gender was male, 
site was Site 1 and the reference category for network member type was the GP. A multi-
level version of the models was then fitted adding a patient level to the data to explore the 
extent of the tie value variation between patients. These allowed inference about whether 
the perceived importance of network ties varied from patient to patient as well as by type. 
The data were prepared in a multi-level structure with the patient at level 2 and their network 
members at level 1.
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8The multi-level logistic regression model can be summarised as:
jijij u+= βX')logit(π
The dependent variable is whether the network member is highly important to the patient, 
therefore πij is the probability that the tie between the network member i and patient j is of 
high importance. X′ijβ model fixed effects that may be characteristics of the patient (e.g. age 
or gender) or the network member (e.g. professional role). uj is a normally distributed 
random effect for the intercept of the regression model at the patient level (Level 2), where  
. Level 1 variation between network members of the same patient (with the ),0(~ 2uj Nu σ
same fixed factors) is Bernoulli.
Following previous applications of this method,27 28 we have assumed no overlap between 
networks; no member of one patient’s network was assumed to be a member of another 
patient’s network. Model estimation was achieved via a Markov Chain Monte Carlo method 
(MCMC), and the goodness of fit of the various models was compared using the Bayesian 
Deviance Information Criterion (DIC). The residuals of the best fitting model were analysed 
and extreme cases, not following the typical patterns of ties expected by the model, were 
explored qualitatively to understand more about their post-discharge experiences. This 
sequential mixed methods analysis combining interview data with quantitative network 
analysis allowed in-depth interpretation of the networks data and offered contextual 
information to the network strucutres.29
Results
75 patients were recruited to the study; 15 were lost to follow-up because: the study team 
could not contact them (3), they did not wish to take part (3), they were ill (7), and two 
patients died. 60 patients were retained in the study, 39 of whom kept diary records and 60 
took part in interviews. One patient was interviewed 12 weeks following discharge because 
he had been readmitted for surgery. Patients’ ages ranged from 35–80 (m 62; SD 10.3), 42 
were male and 18 were female. 
Descriptive analysis
In total, 60 patients reported 383 medicines contacts with a mean network size of 6.47 
people (SD 2.72) and a range of 1–15. Overall, patients reported more professional than 
personal contacts (friends and family and spouses) in their networks. Most professionals 
were clinical, including GPs, GP practice nurses, hospital nurses, hospital doctors, 
community pharmacists and specialist cardiology nurses. Each patient had contact with at 
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9least one healthcare professional or support staff member. In total, 60 patients had 273 such 
contacts. GPs (n=56) were the most commonly reported healthcare professional type, 
although a quarter of the sample had no direct GP contact. There were 53 nurses (other 
than specialist cardiology nurses) who were GP practice-based, clinic-based, and also 
hospital-based. Just over half of patients (43) recounted contact with community 
pharmacists. Cardiac rehabilitation nurses or heart failure nurses were present in the 
networks of 35 patients. Informal contacts included spouses (8% of all network members) 
and other family members and friends (20%) such as children, parents and siblings, friends 
and neighbours. Relatives, such as in-laws and cousins, also featured along with other 
people patients knew but were not close to, for example acquaintances at church. Some of 
these informal contacts had healthcare experience, e.g. they were GPs, current and former 
nurses, and healthcare assistants. 
Patients attributed the highest importance to over two fifths of their network members (44%) 
and spouses commonly attracted the highest ratings. GP receptionists attracted the most 
negative assessments by patients with nearly half being placed in the lowest value category 
by patients. Table 2 shows the number of people in each category and the importance 
placed on them by patients.
Table 1: Network member types and importance ratings. Numbers are reversed so that 4 in the highest 
importance and 1 is the lowest importance.
Type of network member Number (reversed) in each importance rating (%)
1 2 3 4 Total
GPs 10 (17.9) 6 (10.7) 12 (21.4) 28 (50) 56
Friends/Family 9 (11.5) 17 (21.8) 20 (25.6) 32 (41) 78
Hospital doctors 1 (4.5) 7 (31.8) 5 (22.7) 9 (40.9) 22
Spouses 2 (6.3) 2 (6.3) 5 (15.6%) 23 (71.9) 32
Specialist cardiology nurses 2 (5.7) 3 (8.6) 8 (22.9) 22 (62.9) 35
Other nurses 4 (7.5) 9 (17) 15 (28.3) 25 (47.2) 53
Community pharmacy staff 5 (15.2) 10 (30.3) 12 (36.4) 6 (18.2) 33
Community pharmacists 3 (7) 11 (25.6) 13 (30.2) 16 (37.2) 43
Others 1 (12.5) 1 (12.5) 2 (25) 4 (50) 8
GP receptionists 11 (47.8) 3 (13) 6 (26.1) 3 (13) 23
Total 48 69 98 168 383
Total (%) 12.5% 18% 25.6% 43.9% 100%
Single-level model of the network ties
Model 1 in Table 3 was a single-level logistic regression of the likelihood of a network 
member being highly important to the patient – fitted mainly as a baseline model to be 
compared for goodness of fit with the more realistically complex multi-level model. 
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10
Compared with GPs, all healthcare staff network members were less likely to be highly 
important members of patients’ networks. Patients’ spouses were significantly more likely to 
be highly important network members (p=<0.05 (CI 0.03 – 1.971)). Increase in age was also 
significantly more likely to positively impact on network ratings (p=<0.01(CI 0.008 – 0.0516)). 
GP reception staff (p=<0.01(CI -3.658 – -0.813) and community pharmacy staff (not 
pharmacists) (p=<0.01(CI -2.755 – -0.589)) were significantly less likely to be highly rated.
Multi-level model of the network ties
Multi-level models better represent these patient networks and allow the nature and extent of 
variation in ties between and within patient networks. Model 2 in Table 4 is a multi-level 
logistic regression of the likelihood of a tie being highly rated by the patient. It has a reduced 
DIC of 495.29, indicating that controlling for patient-level variation improves the statistical 
model fit. In this model, increasing age still significantly increases the likelihood that network 
ties will be highly important to patients (p<0.05 (CI 0.003 – 0.065). Spouses are also still 
significantly more likely than GPs to be highly important network members (p<0.05 (CI 0.112 
– 2.218)) and the likelihood of ties to community pharmacy staff (p=0.001 (CI -3.247 – -
0.827)) and to GP receptionists (p<0.01 (CI -4.147 – -1.032)) being highly rated is reduced 
compared to GPs.
Table 2: Model 1 – Single-level logistic regression of the likelihood of a network tie being of high value to the patient. 
Reference categories: male patient; site 1; GP network member.
Deviation Information Criteria (DIC) = 505.645  ** p<0.01  *p<0.05  
Co-efficient SE P CI lower CI Upper
Intercept -1.645 0.727  0.0236 * -3.065 -0.242
Patient age 0.030 0.011 0.008 ** 0.008 0.052
Patient 
female
0.199 0.241   0.409 -0.270 0.670
Site 2 -0.413    0.361 0.080 -0.881 0.045
Friend / 
family
-0.437 0.528 0.407 -1.479 0.573
Hospital 
doctor
-0.518     0.503 0.303 -1.511 0.484
Spouse 0.981     0.496 0.048 * 0.030 1.971
Specialist 
cardio nurse
0.513  0.449  0.253 -0.359 1.401
Other nurse -0.120     0.399 0.763 -0.905 0.663
Community 
pharmacy 
staff
-1.608 0.549 0.003 ** -2.755 -0.589
Community 
pharmacist
-0.644     0.430 0.134 -1.498 0.203
Other -0.063 0.803 0.937 -1.534 1.642
GP reception -2.123 0.726  0.003 ** -3.657 -0.813
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Table 3: Model 2 – Multi-level logistic regression of the likelihood of a network tie being of high importance to the 
patient. Level 1 network members; level 2 patients. Reference categories: male patient; site 1; network member GP.
Deviation Information Criteria (DIC) = 495.293   ** p<0.01  *p<0.05  
Fixed part estimates
Co-efficient SE P CI lower CI upper
Intercept -1.863 1.028 0.070 -3.858 0.110
Patient age 0.034 0.016 0.032 * 0.003 0.065
Patient 
female
0.159 0.349 0.650 -0.533 0.851
Site 2 -0.447 0.321 0.163 -1.086 0.194
Friend / 
family
-0.339 0.402 0.399 -1.130 0.439
Hospital 
doctor
-0.268 0.580 0.644 -1.405 0.860
Spouse 1.129 0.537 0.036 * 0.112 2.218
Specialist 
cardio nurse
0.600  0.500 0.230 -0.371 1.581
Other nurse -0.117 0.437 0.789 -0.976 0.750
Community 
pharmacy 
staff
-1.973 0.620 0.001 ** -3.247 -0.827
Community 
pharmacist
-0.738 0.463 0.111 -1.659 0.157
Other 0.064 0.884 0.942 -1.674 1.809
GP reception 
staff
-2.451 0.790 0.002 ** -4.147 -1.032
Random part estimates at the patient level
Co-efficient SE CI lower CI upper
Intercept 0.5636 0.404 0.002 1.561
Analysis of the model residuals
We analysed the residuals for the best fitting model (Model 2) to see, having controlled for 
the explanatory variables in the model, which patients valued their networks on average 
more highly than others and which patients attributed lower values on average (extreme 
cases). A caterpillar plot of the residuals for Model 2 is in Figure 2 and the extreme residuals 
are presented in Tables 4 and 5 for the tail and head of the residuals plot. We then explored 
the composition of those networks and the patients’ experiences of managing their 
medicines. Cases with extreme residuals indicated the patients for whom tie variation cannot 
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be explained well by the model and further qualitative assessment of these cases was 
carried out. 
Figure 2: Caterpillar plot of the residuals of Model 2
Table 4: Extreme residuals for Model 2 (Head) 
Patient ID Residuals Lower 95% CI Upper 95% CI
 18 -1.9 -3.4 -0.39
13 -1.7 -2.9 -0.61
 50 -1.6 -3.1 -0.14
Table 5: Extreme residuals for Model 2 (Tail) 
Patient ID Residuals Lower 95% CI Upper 95% CI
54 1.3 0.1 2.4
48 1.6 0.3 2.9
47 1.7 0.2 3.2
25 2.5 0.9 4.2
After fitting Model 2, three patients recorded lower values for their network ties than other 
patients. Here we describe their experiences in more depth. Patient 18 had no spouse or 
other friends or family support with medicines and felt that little information had been given 
to her in the hospital about newly prescribed medicines. Overall, this patient described being 
frustrated with the levels of medicines-related care she had experienced. She described 
feeling “like I’m 50%, I’m not 100%”. She had been given incorrect information by the 
hospital about discontinuing a medicine in advance of a test, which had annoyed her, and 
described having low levels of confidence in the efficacy of her medicines and that her health 
conditions and response to her medicines were not being effectively managed.
“I believe that they [health professionals] should think, ‘well she’s still got the hypertension, 
which I’ll have but it’s ridiculously high, she’s maxed out on all of her blood pressure tablets 
and the majority of the angina medication, she’s already had a heart attack, the angina is 
more prevalent than it was before the heart attack, we should really be getting her sorted 
out.’” (Patient 18)
Patient 13 had a large medicines management network with six friends and family members 
and a range of staff from different healthcare organisations providing medicines 
management functions for the patient’s cardiology conditions and other co-morbidities. He 
did consider some of his healthcare professionals, such as his GP, to be important; however 
none of his informal network, including his spouse, was highly valued. This patient ordered 
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his medicines himself using the GP practice’s online system and checked for himself the list 
of available medicines against the hospital discharge note. He attributed the highest value to 
his GP and hospital cardiologist and perceived much less value in the rest of his care team. 
In particular his usual community pharmacist was given the lowest value because he 
appraised their function and availability to be limited.
“Well, I don't always see the chemist when I go… I may be wrong, but they can't change [the 
medicines], they have to go through a GP, or a consultant anyhow.” (Patient 13)
Patient 50 described discontinuing two of her medicines during the immediate post-
discharge period because she didn’t understand why she needed to take them. She had 
asked for help from her spouse in organising her supplies but this had not been forthcoming. 
She also felt that healthcare staff had not taken into account her preferences, for example 
not wishing to take statins. She described perceiving the need to be given more explanation 
about the function of medicines and the reason for needing to take them. 
“Regards medicines, I think what would have been nice, is somebody with communication 
skills to sit in a private room, just you and them, and work through what had happened to 
you, what you need and why you need it basically, a bit like a proper GP consultation, but 
with a pharmacist who’s got some good communication and people skills.” (Patient 50)
Four patients recorded higher values for their network ties than others. Their experiences 
are laid out below.
Patient 25 attributed high importance to everyone in her network. She had unanswered 
questions about her medicines but blamed herself for not asking anyone about them. This 
patient valued the role of GP receptionists and pharmacy staff in supplying her with 
medicines and communicating efficiently. She also appreciated the relationship she had 
developed over time with the GP reception staff.
“Well I have known them for a long time, I have been with them for years, so when I phone 
up they actually know who I am to start with. They just seem to know what you want when I 
am phoning for my medication. Like we will send it to the chemist, they are really good.” 
(Patient 25)
Patient 47 had a small network comprising her GP, community pharmacist, the pharmacy 
delivery driver and her sister. She described having no problems with her medicines since 
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leaving the hospital and explained that the services of her community pharmacist and 
pharmacy delivery driver were important and she valued them for their reliability and the 
convenience of having medicines delivered.
“He [the pharmacy delivery driver] delivers them, doesn’t he?  Without him I’d have to go find 
them myself, wouldn’t I?” (Patient 47)
Patient 48 had a network of seven people, six of whom were healthcare staff. She described 
her daughter as acting as her advocate with the healthcare team. She had experienced side-
effects whilst taking a beta-blocker but her GP had taken action and she described not 
needing to talk with anyone about here medicines because “I just take them and get on with 
it”. Nevertheless she felt confident that her GP, other practice staff and staff at her 
community pharmacy were approachable if she had problems with her medicines.
“No, they always say, any problems at all you’re not wasting [our time]…because I always 
think I’m wasting their time. [My GP] has talked to me on the phone before, he did last time 
when I told him about [my problems with] these beta-blockers.” (Patient 48)
Patient 54 had a network of six people, five of whom were members of the healthcare team. 
He placed importance on a pacemaker technician who advised him to take the prescribed 
dose of beta-blocker after the patient had told him he had decided to take half the dose. He 
felt he had a good relationship with his GP, however, he was critical of the GP practice 
receptionist staff who he thought provided poor service and his new medicines had also 
been missing from his repeat prescription. This patient, however, praised the staff at his 
community pharmacy for their helpfulness.
“They [community pharmacy staff] are brilliant, they are really good, they are and extremely 
helpful, they make you feel that you need... that you know they are there to help you.” 
(Patient 54)
Discussion
We found that patients discharged from cardiology wards have individual medicines 
management networks with different compositions and different sizes that included clinical 
and non-clinical staff and friends and family members. Over two fifths of the people in 
patients’ networks were perceived to be highly important in managing medicines. We also 
found that not all patients had contact with GPs and community pharmacists following their 
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discharge, however all patients did have contact with at least one formal healthcare staff 
member. Older patients were more likely to perceive highly important network ties. Patients’ 
spouses were significantly more likely than other network members to be highly important 
whilst community pharmacy staff and GP reception staff were less likely to be highly rated. 
By analysing the residuals of the best fitting model it was possible to identify patients who 
did not have the typical range of tie values. Some of these patients described not having 
enough information about their medicines and needing support in organising them once 
home from hospital. Others lacked confidence in their efficacy and had stopped taking them. 
Patients with more positive assessments of their networks described valuing the 
relationships they had developed over time with their care team. 
In common with other studies, patients had medicines network members who were friends or 
family members.17 19 Not all patients had this type of informal support, although each patient 
did have contact with at least one healthcare professional or healthcare support staff 
member. In our sample, increase in age positively impacted on the likelihood of patients 
perceiving their network members as highly important.  Older patients have previously been 
found to have high expectations of their care team and to have those expectations met,30 
however older patients and their carers have also reported poor experiences of the 
medicines care they receive after leaving hospital, and to lack knowledge of their 
medicines.4 31 This may result in older patients perceiving their care and informal support 
networks to be more important to them as they require more input post-discharge. 
All network members were on average less likely to be highly valued by patients than GPs 
apart from their spouse and their specialist cardiology nurses, although the latter not 
significantly so. This emphasises the continued, perceived importance of patients’ GPs in 
managing their medicines after a period in hospital, despite the reports some patients make 
about not being able to access GP services easily. GP receptionists and community 
pharmacy staff were not highly valued by the patients that came into contact with them. This 
contradicts evidence that patients tend to be satisfied with primary care experiences and 
they have confidence and trust in their healthcare teams.32 It might also reflect views that 
non-clinical staff play less important roles in healthcare, However GP receptionists perform 
pivotal medicines management functions,33 34 albeit not always patient-facing functions, 
which demand problem-solving, good judgement and a focus on patient safety. 
Receptionists often need to make decisions balancing patient needs with the availability of 
services, which can appear as ‘gatekeeping’ to the patient.33 Patients engage with pharmacy 
delivery drivers delivering to their homes and community pharmacy staff who may act as a 
proxy for contact with a community pharmacist and they may not see a pharmacist in 
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person. Because patients do not automatically have contact with a community pharmacist 
after their discharge and many do not see their GP, opportunities to support their medicines 
use may be missed.
The ego-net approach to exploring a complex system
Using the ego-net approach we were able to construct patients’ networks as patients 
experienced them, rather than how this healthcare system was designed to be delivered. 
Here, the patient was in the role of perceiver of their system in the form of ties to others 
concerning their medicines, rather than simply those that routinely and explicitly appear 
between professionals in care delivery. The networks reflect patient access of formal 
healthcare services and the availability of informal social support resources to access 
medicines. The multi-level model was able to reflect how individual patients’ networks were 
valued differently at the individual level; and that every person’s experience of healthcare is 
different. During the study, exploring personal interactions was invaluable in understanding 
how the system manifested itself to patients. The networks patients described were sets of 
independent actors working in parallel to meet the goal of managing medicines.10 In our 
study membership of each patient-described network varied and changed according to their 
needs, preferences and ability to adapt following their admission to the hospital, and the 
availability of services and support. The systems patients described were embedded within 
other systems and by nature would overlap with other systems, for example one GP would 
treat many patients but each of those patients would have different specialist clinicians 
managing their medicines and different people providing informal support. These medicines 
management systems also co-existed and interacted with other healthcare systems, for 
example those that commission healthcare services, or run primary care or hospital 
services.11 Moreover, patients themselves are complex, and are faced with social, economic, 
personal, biological, and clinical circumstances which are also variable and unpredictable 
and these combined forces impact on how they respond to or manage treatment and care 
services.35 36
Implications for policy
An important measure of the quality of healthcare is whether it provides care designed to 
meet individual patient’s needs.37 This research has demonstrated that every person’s 
experience of medicines management is individual, however, the extent to which the care 
that patients experience is individualised or tailored to their needs and values is 
questionable. Patient-centred approaches are key to the successful optimisation of 
medicines.38 It is undeniable that patients access the services of many different healthcare 
practitioners during this period of their recovery and in this sense they are managing one-to-
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many relationships with their care teams in the course of their medicines self-management. 
Patients in other research have described this as burdensome,4 and even if patients 
experienced individual, patient-centred encounters with a clinician, such as a cardiac 
rehabilitation nurse, the overall system itself may not have been calibrated to deliver patient-
centred medicines management. Interventions have attempted to enhance the patient-
centredness of medicines management, although few have been delivered by 
multidisciplinary teams.39 Policy must address, therefore, how an integrated patient-centred 
medicines management process could be designed and embedded to make it an actionable 
goal for all care providers within healthcare economies. 
The data suggest that there are inconsistencies in the support patients access to manage 
their medicines once they leave the hospital. Whilst this in part reflects individual variation in 
patients’ care needs and the complexity in the system, after leaving the hospital one in four 
patients had no contact with a GP who may be expected to have an overview of the care 
patients receive from different healthcare professionals and the different treatments 
prescribed for different chronic conditions. The UK NICE guidance stresses how medicines 
optimisation should be focussed on the involvement of all HCPs and social care 
professionals involved in the patient’s care and that professional collaboration across 
healthcare settings is required.38 It is difficult to ascertain what consideration is given to 
patients’ hospital discharge and medicines by somebody in primary care looking across 
patients’ co-morbidities and their subsequent appointments with specialists in their different 
health conditions. Given that changes to medicines made by one clinician can impact on the 
patient’s co-morbidities, consideration needs to be given to drug-condition interactions. 
Policy has attempted to extend and expand the role of community pharmacists in supporting 
patients with their medicines and build patient knowledge of their medicines over time to 
complement the care they receive from their GP and reduce the demand for GP services.40 
41 In the UK patients usually receive a supply of medicines in hospital to take home and then 
receive a follow-up prescription from their GP, which they then would access a community 
pharmacy to dispense. This differs from the way care is organised in other countries, for 
example in the USA where patients are not given supplies at discharge. Community 
pharmacists have also been commissioned to provide a Medicines Use Review and 
Prescription Intervention Service (MURs) in England and Wales since 2005 which aims to 
ensure that patients understand their medicines, identify problems patients might be 
experiencing and provide feedback to the prescriber. There are currently four target groups 
for MURs, which include those who have recently been discharged from the hospital with 
changes made to their medicines and patients with cardiovascular conditions. In this study 
945
946
947
948
949
950
951
952
953
954
955
956
957
958
959
960
961
962
963
964
965
966
967
968
969
970
971
972
973
974
975
976
977
978
979
980
981
982
983
984
985
986
987
988
989
990
991
992
993
994
995
996
997
998
999
1000
1001
1002
1003
18
community pharmacists were not universally present in patients’ networks and, compared 
with GPs, they were not important network members. Our findings suggest that community 
pharmacy services could be better integrated into the post-discharge pathway to support 
patients in using their medicines following a period in hospital, especially as their information 
and support needs may change after discharge.42 In addition the increase in GP practice-
based pharmacists may provide an additional resource to optimise treatment across health 
conditions and clinical specialisms.43
Implications for further research
The research has expanded our understanding that informal  contacts are leveraged by 
many patients to gain support in medicines management. Spouses in particular played 
highly valued roles for patients. It is accepted that people’s social networks impact on their 
health and wellbeing,44 45 our study has shown the informal networks surrounding patients 
are as important to them as more formal healthcare practitioners and that people’s health 
and treatment is experienced through social ties, either through personal contacts supporting 
and facilitating recovery and access to treatment, or through the social context in which 
people experience socio-technical healthcare systems. There is a clear opportunity for SNA 
to explore and understand more about people’s behaviours and experiences with their 
medicines. Whole network approaches can be adopted to explore healthcare systems which 
include patients.46
Limitations
This work focused on a single health condition, and although the findings from this study 
cannot be generalised to the broader patient population, patients with a range of different 
health conditions are likely to share some of the same experiences in the post-discharge 
management of their medicines. The necessity to conduct a relatively small sample study to 
determine the extent of patients’ networks through face-to-face interview methods meant 
that the quantitative data analysis does not aim to be statistically inferential. This was a 
cross-sectional study that mapped patients’ networks and is subject to some of the inherent 
biases of this approach. This approach did not allow us to take into account the temporal 
order of medicines management care or support patients were able to access. In theory, this 
data might have been available in patient diaries, however not all patients felt able to keep a 
diary. The networks represented patients’ views of the medicines management system and 
this project did not attempt to corroborate their views with other sources of data such as their 
medical records or the views of healthcare professionals and informal carers. Patients’ 
experiences of healthcare systems are, however, important data in determining the quality 
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and safety of care. Networks were recorded or described by patients who may not have 
accurately noted or recalled their medicines management interactions.
Conclusion
Patients experience medicines management as individual systems comprising healthcare 
staff and personal contacts and patients value system components individually. Analysing 
the model residuals from the quantitative analysis, and exploring patients’ experiences 
qualitatively was a novel application of mixed methods to network data. There are 
opportunities to improve how medicines are managed to reflect the care and support needs 
of individuals so that it is person-centred. Using this ego-net approach it is possible to 
understand this complex healthcare system as patients experienced it, rather than how 
policy suggests it is delivered. 
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Figure 1: An example of the hierarchical network took used to capture patients' ego-nets
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Figure 2: Caterpillar plot of the residuals of Model 2
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